<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38550582</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial extracellular vesicles, autoimmunity and myocarditis.</ArticleTitle><Pagination><StartPage>1374796</StartPage><MedlinePgn>1374796</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1374796</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1374796</ELocationID><Abstract><AbstractText>For many decades viral infections have been suspected as 'triggers' of autoimmune disease, but mechanisms for how this could occur have been difficult to establish. Recent studies have shown that viral infections that are commonly associated with viral myocarditis and other autoimmune diseases such as coxsackievirus B3 (CVB3) and SARS-CoV-2 target mitochondria and are released from cells in mitochondrial vesicles that are able to activate the innate immune response. Studies have shown that Toll-like receptor (TLR)4 and the inflammasome pathway are activated by mitochondrial components. Autoreactivity against cardiac myosin and heart-specific immune responses that occur after infection with viruses where the heart is not the primary site of infection (e.g., CVB3, SARS-CoV-2) may occur because the heart has the highest density of mitochondria in the body. Evidence exists for autoantibodies against mitochondrial antigens in patients with myocarditis and dilated cardiomyopathy. Defects in tolerance mechanisms like autoimmune regulator gene (AIRE) may further increase the likelihood of autoreactivity against mitochondrial antigens leading to autoimmune disease. The focus of this review is to summarize current literature regarding the role of viral infection in the production of extracellular vesicles containing mitochondria and virus and the development of myocarditis.</AbstractText><CopyrightInformation>Copyright © 2024 Di Florio, Beetler, McCabe, Sin, Ikezu and Fairweather.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Di Florio</LastName><ForeName>Damian N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beetler</LastName><ForeName>Danielle J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCabe</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sin</LastName><ForeName>Jon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Alabama, Tuscaloosa, AL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikezu</LastName><ForeName>Tsuneya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fairweather</LastName><ForeName>DeLisa</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR002556</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI154927</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI152318</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI145356</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL164520</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>TL1 TR002380</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="Y">Extracellular Vesicles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AIRE</Keyword><Keyword MajorTopicYN="N">autoimmune disease</Keyword><Keyword MajorTopicYN="N">coxsackievirus</Keyword><Keyword MajorTopicYN="N">extracellular vesicles</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">mitochondrial-derived vesicles</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>4</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38550582</ArticleId><ArticleId IdType="pmc">PMC10972887</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1374796</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sogkas G, Atschekzei F, Adriawan IR, Dubrowinskaja N, Witte T, Schmidt RE. Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity. Cell Mol Immunol. (2021) 18:1122–40. doi: 10.1038/s41423-020-00626-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00626-z</ArticleId><ArticleId IdType="pmc">PMC8015752</ArticleId><ArticleId IdType="pubmed">33795850</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR. From infection to autoimmunity. J Autoimmun. (2001) 16:175–86. doi: 10.1006/jaut.2000.0492</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jaut.2000.0492</ArticleId><ArticleId IdType="pubmed">11334481</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamim EA, Miller FW. Familial autoimmunity and the idiopathic inflammatory myopathies. Curr Rheumatol Rep. (2000) 2:201–11. doi: 10.1007/s11926-000-0080-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-000-0080-0</ArticleId><ArticleId IdType="pubmed">11123060</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Root-Bernstein R. Autoimmune disease: Mechanism. In: Encyclopedia of life sciences. John Wiley &amp; Sons, Ltd, Chichester, UK: (2015). p. 1–7. doi: 10.1002/9780470015902.a0020193.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780470015902.a0020193.pub2</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Rose NR. Type 1 diabetes: Virus infection or autoimmune disease? Nat Immunol. (2002) 3:338–40. doi: 10.1038/ni0402-338</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni0402-338</ArticleId><ArticleId IdType="pubmed">11919574</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas OG, Olsson T. Mimicking the brain: Epstein-Barr virus and foreign agents as drivers of neuroimmune attack in multiple sclerosis. Front Immunol. (2023) 14:1304281. doi: 10.3389/fimmu.2023.1304281</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1304281</ArticleId><ArticleId IdType="pmc">PMC10655090</ArticleId><ArticleId IdType="pubmed">38022632</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciferri MC, Quarto R, Tasso R. Extracellular vesicles as biomarkers and therapeutic tools: from pre-clinical to clinical applications. Biol (Basel). (2021) 10:359. doi: 10.3390/biology10050359</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10050359</ArticleId><ArticleId IdType="pmc">PMC8145169</ArticleId><ArticleId IdType="pubmed">33922446</ArticleId></ArticleIdList></Reference><Reference><Citation>Beetler DJ, Di Florio DN, Law EW, Groen CM, Windebank AJ, Peterson QP, et al. . The evolving regulatory landscape in regenerative medicine. Mol Aspects Med. (2023) 91:101138. doi: 10.1016/j.mam.2022.101138</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2022.101138</ArticleId><ArticleId IdType="pmc">PMC10162454</ArticleId><ArticleId IdType="pubmed">36050142</ArticleId></ArticleIdList></Reference><Reference><Citation>Thery C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. . Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. (2018) 7:1535750. doi: 10.1080/20013078.2018.1535750</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2018.1535750</ArticleId><ArticleId IdType="pmc">PMC6322352</ArticleId><ArticleId IdType="pubmed">30637094</ArticleId></ArticleIdList></Reference><Reference><Citation>Witwer KW, Goberdhan DC, O'Driscoll L, Thery C, Welsh JA, Blenkiron C, et al. . Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles. J Extracell Vesicles. (2021) 10:e12182. doi: 10.1002/jev2.12182</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12182</ArticleId><ArticleId IdType="pmc">PMC8710080</ArticleId><ArticleId IdType="pubmed">34953156</ArticleId></ArticleIdList></Reference><Reference><Citation>Yates AG, Pink RC, Erdbrugger U, Siljander PR, Dellar ER, Pantazi P, et al. . In sickness and health: The functional role of extracellular vesicles in physiology and pathology in in vivo: Part II: Pathology. J Extracell Vesicles. (2022) 11:e12190. doi: 10.1002/jev2.12190</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12190</ArticleId><ArticleId IdType="pmc">PMC8765328</ArticleId><ArticleId IdType="pubmed">35041301</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues M, Fan J, Lyon C, Wan M, Hu Y. Role of extracellular vesicles in viral and bacterial infections: Pathogenesis, diagnostics, and therapeutics. Theranostics. (2018) 8:2709–21. doi: 10.7150/thno.20576</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.20576</ArticleId><ArticleId IdType="pmc">PMC5957004</ArticleId><ArticleId IdType="pubmed">29774070</ArticleId></ArticleIdList></Reference><Reference><Citation>Admyre C, Bohle B, Johansson SM, Focke-Tejkl M, Valenta R, Scheynius A, et al. . B cell-derived exosomes can present allergen peptides and activate allergen-specific T cells to proliferate and produce TH2-like cytokines. J Allergy Clin Immunol. (2007) 120:1418–24. doi: 10.1016/j.jaci.2007.06.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2007.06.040</ArticleId><ArticleId IdType="pubmed">17868797</ArticleId></ArticleIdList></Reference><Reference><Citation>Beetler DJ, Di Florio DN, Bruno KA, Ikezu T, March KL, Cooper LT, Jr., et al. . Extracellular vesicles as personalized medicine. Mol Aspects Med. (2023) 91:101155. doi: 10.1016/j.mam.2022.101155</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2022.101155</ArticleId><ArticleId IdType="pmc">PMC10073244</ArticleId><ArticleId IdType="pubmed">36456416</ArticleId></ArticleIdList></Reference><Reference><Citation>Beetler DJ, Bruno KA, Watkins MM, Xu V, Chekuri I, Giresi P, et al. . Reconstituted extracellular vesicles from human platelets decrease viral myocarditis in mice. Small. (2023) 19:e2303317. doi: 10.1002/smll.202303317</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/smll.202303317</ArticleId><ArticleId IdType="pmc">PMC10840864</ArticleId><ArticleId IdType="pubmed">37612820</ArticleId></ArticleIdList></Reference><Reference><Citation>Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, et al. . B lymphocytes secrete antigen-presenting vesicles. J Exp Med. (1996) 183:1161–72. doi: 10.1084/jem.183.3.1161</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.183.3.1161</ArticleId><ArticleId IdType="pmc">PMC2192324</ArticleId><ArticleId IdType="pubmed">8642258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang I, Shen X, Sprent J. Direct stimulation of naive T cells by membrane vesicles from antigen-presenting cells: distinct roles for CD54 and B7 molecules. Proc Natl Acad Sci U S A. (2003) 100:6670–5. doi: 10.1073/pnas.1131852100</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1131852100</ArticleId><ArticleId IdType="pmc">PMC164505</ArticleId><ArticleId IdType="pubmed">12743365</ArticleId></ArticleIdList></Reference><Reference><Citation>Thery C, Zitvogel L, Amigorena S. Exosomes: Composition, biogenesis and function. Nat Rev Immunol. (2002) 2:569–79. doi: 10.1038/nri855</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri855</ArticleId><ArticleId IdType="pubmed">12154376</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z, Hensley L, McKnight KL, Hu F, Madden V, Ping L, et al. . A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature. (2013) 496:367–71. doi: 10.1038/nature12029</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12029</ArticleId><ArticleId IdType="pmc">PMC3631468</ArticleId><ArticleId IdType="pubmed">23542590</ArticleId></ArticleIdList></Reference><Reference><Citation>Alenquer M, Amorim MJ. Exosome biogenesis, regulation, and function in viral infection. Viruses. (2015) 7:5066–83. doi: 10.3390/v7092862</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7092862</ArticleId><ArticleId IdType="pmc">PMC4584306</ArticleId><ArticleId IdType="pubmed">26393640</ArticleId></ArticleIdList></Reference><Reference><Citation>Schorey JS, Harding CV. Extracellular vesicles and infectious diseases: New complexity to an old story. J Clin Invest. (2016) 126:1181–9. doi: 10.1172/JCI81132</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI81132</ArticleId><ArticleId IdType="pmc">PMC4811125</ArticleId><ArticleId IdType="pubmed">27035809</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Rodriguez J, Alba MA, Prieto-Gonzalez S, Cid MC. Diagnosis and classification of polyarteritis nodosa. J Autoimmun. (2014) 48–49:84–9. doi: 10.1016/j.jaut.2014.01.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2014.01.029</ArticleId><ArticleId IdType="pubmed">24485157</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J, Casella G, Zhang Y, Rostami A, Li X. Potential roles of extracellular vesicles in the pathophysiology, diagnosis, and treatment of autoimmune diseases. Int J Biol Sci. (2020) 16:620–32. doi: 10.7150/ijbs.39629</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.39629</ArticleId><ArticleId IdType="pmc">PMC6990925</ArticleId><ArticleId IdType="pubmed">32025210</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellam J, Proulle V, Jungel A, Ittah M, Miceli Richard C, Gottenberg JE, et al. . Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther. (2009) 11:R156. doi: 10.1186/ar2833</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2833</ArticleId><ArticleId IdType="pmc">PMC2787287</ArticleId><ArticleId IdType="pubmed">19832990</ArticleId></ArticleIdList></Reference><Reference><Citation>Mobarrez F, Fuzzi E, Gunnarsson I, Larsson A, Eketjall S, Pisetsky DS, et al. . Microparticles in the blood of patients with SLE: Size, content of mitochondria and role in circulating immune complexes. J Autoimmun. (2019) 102:142–9. doi: 10.1016/j.jaut.2019.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.05.003</ArticleId><ArticleId IdType="pubmed">31103269</ArticleId></ArticleIdList></Reference><Reference><Citation>Saenz-Cuesta M, Irizar H, Castillo-Trivino T, Munoz-Culla M, Osorio-Querejeta I, Prada A, et al. . Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis. Biomark Med. (2014) 8:653–61. doi: 10.2217/bmm.14.9</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm.14.9</ArticleId><ArticleId IdType="pubmed">25123034</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimkhani S, Vafaee F, Young PE, Hur SSJ, Hawke S, Devenney E, et al. . Exosomal microRNA signatures in multiple sclerosis reflect disease status. Sci Rep. (2017) 7:14293. doi: 10.1038/s41598-017-14301-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14301-3</ArticleId><ArticleId IdType="pmc">PMC5662562</ArticleId><ArticleId IdType="pubmed">29084979</ArticleId></ArticleIdList></Reference><Reference><Citation>Selmaj I, Cichalewska M, Namiecinska M, Galazka G, Horzelski W, Selmaj KW, et al. . Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Ann Neurol. (2017) 81:703–17. doi: 10.1002/ana.24931</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24931</ArticleId><ArticleId IdType="pubmed">28411393</ArticleId></ArticleIdList></Reference><Reference><Citation>Guay C, Kruit JK, Rome S, Menoud V, Mulder NL, Jurdzinski A, et al. . Lymphocyte-derived exosomal microRNAs promote pancreatic beta cell death and may contribute to type 1 diabetes development. Cell Metab. (2019) 29:348–361.e6. doi: 10.1016/j.cmet.2018.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2018.09.011</ArticleId><ArticleId IdType="pubmed">30318337</ArticleId></ArticleIdList></Reference><Reference><Citation>Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, et al. . Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science. (2010) 327:580–3. doi: 10.1126/science.1181928</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181928</ArticleId><ArticleId IdType="pmc">PMC2927861</ArticleId><ArticleId IdType="pubmed">20110505</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinuela-Berni V, Doniz-Padilla L, Figueroa-Vega N, Portillo-Salazar H, Abud-Mendoza C, Baranda L, et al. . Proportions of several types of plasma and urine microparticles are increased in patients with rheumatoid arthritis with active disease. Clin Exp Immunol. (2015) 180:442–51. doi: 10.1111/cei.12598</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12598</ArticleId><ArticleId IdType="pmc">PMC4449772</ArticleId><ArticleId IdType="pubmed">25639560</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Cicero A, Majkowska I, Nagase H, Di Liegro I, Troeberg L. Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity. Matrix Biol. (2012) 31:229–33. doi: 10.1016/j.matbio.2012.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2012.02.005</ArticleId><ArticleId IdType="pmc">PMC3391679</ArticleId><ArticleId IdType="pubmed">22406378</ArticleId></ArticleIdList></Reference><Reference><Citation>Headland SE, Jones HR, Norling LV, Kim A, Souza PR, Corsiero E, et al. . Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis. Sci Transl Med. (2015) 7:315ra190. doi: 10.1126/scitranslmed.aac5608</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aac5608</ArticleId><ArticleId IdType="pmc">PMC6034622</ArticleId><ArticleId IdType="pubmed">26606969</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui X, Liu Y, Wang S, Zhao N, Qin J, Li Y, et al. . Circulating exosomes activate dendritic cells and induce unbalanced CD4+ T cell differentiation in Hashimoto thyroiditis. J Clin Endocrinol Metab. (2019) 104:4607–18. doi: 10.1210/jc.2019-00273</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2019-00273</ArticleId><ArticleId IdType="pubmed">31199456</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigemoto-Kuroda T, Oh JY, Kim DK, Jeong HJ, Park SY, Lee HJ, et al. . MSC-derived extracellular vesicles attenuate immune responses in two autoimmune murine models: Type 1 diabetes and uveoretinitis. Stem Cell Rep. (2017) 8:1214–25. doi: 10.1016/j.stemcr.2017.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.04.008</ArticleId><ArticleId IdType="pmc">PMC5425726</ArticleId><ArticleId IdType="pubmed">28494937</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieker J, Hilbrands L, Thielen A, Dijkman H, Berden JH, van der Vlag J. Enhanced activation of dendritic cells by autologous apoptotic microvesicles in MRL/lpr mice. Arthritis Res Ther. (2015) 17:103. doi: 10.1186/s13075-015-0617-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-015-0617-2</ArticleId><ArticleId IdType="pmc">PMC4422546</ArticleId><ArticleId IdType="pubmed">25886192</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloutier N, Tan S, Boudreau LH, Cramb C, Subbaiah R, Lahey L, et al. . The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: The microparticle-associated immune complexes. EMBO Mol Med. (2013) 5:235–49. doi: 10.1002/emmm.201201846</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201201846</ArticleId><ArticleId IdType="pmc">PMC3569640</ArticleId><ArticleId IdType="pubmed">23165896</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen CT, Ostergaard O, Stener L, Iversen LV, Truedsson L, Gullstrand B, et al. . Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. Arthritis Rheumatol. (2012) 64:1227–36. doi: 10.1002/art.34381</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34381</ArticleId><ArticleId IdType="pubmed">22238051</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Frisancho-Kiss S, Njoku DB, Nyland JF, Kaya Z, Yusung SA, et al. . Complement receptor 1 and 2 deficiency increases coxsackievirus B3-induced myocarditis, dilated cardiomyopathy, and heart failure by increasing macrophages, IL-1beta, and immune complex deposition in the heart. J Immunol. (2006) 176:3516–24. doi: 10.4049/jimmunol.176.6.3516</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.6.3516</ArticleId><ArticleId IdType="pubmed">16517720</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Petri MA, Coronado MJ, Cooper LT. Autoimmune heart disease: Role of sex hormones and autoantibodies in disease pathogenesis. Expert Rev Clin Immunol. (2012) 8:269–84. doi: 10.1586/eci.12.10</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eci.12.10</ArticleId><ArticleId IdType="pmc">PMC3318944</ArticleId><ArticleId IdType="pubmed">22390491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullal AJ, Reich CF, 3rd, Clowse M, Criscione-Schreiber LG, Tochacek M, Monestier M, et al. . Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. J Autoimmun. (2011) 36:173–80. doi: 10.1016/j.jaut.2011.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2011.02.001</ArticleId><ArticleId IdType="pubmed">21376534</ArticleId></ArticleIdList></Reference><Reference><Citation>Rother N, Yanginlar C, Pieterse E, Hilbrands L, van der Vlag J. Microparticles in autoimmunity: Cause or consequence of disease? Front Immunol. (2022) 13:822995. doi: 10.3389/fimmu.2022.822995</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.822995</ArticleId><ArticleId IdType="pmc">PMC9065258</ArticleId><ArticleId IdType="pubmed">35514984</ArticleId></ArticleIdList></Reference><Reference><Citation>She Z, Xie M, Hun M, Abdirahman AS, Li C, Wu F, et al. . Immunoregulatory effects of mitochondria transferred by extracellular vesicles. Front Immunol. (2020) 11:628576. doi: 10.3389/fimmu.2020.628576</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.628576</ArticleId><ArticleId IdType="pmc">PMC7900141</ArticleId><ArticleId IdType="pubmed">33633746</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath V. The spermatid and the sperm of the crab, Paratelphusa spinigera. J Cell Sci. (1932) 75:543–56. doi: 10.1242/jcs.s2-75.299.543</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.s2-75.299.543</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuspiel M, Schauss AC, Braschi E, Zunino R, Rippstein P, Rachubinski RA, et al. . Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. Curr Biol. (2008) 18:102–8. doi: 10.1016/j.cub.2007.12.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2007.12.038</ArticleId><ArticleId IdType="pubmed">18207745</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiura A, McLelland GL, Fon EA, McBride HM. A new pathway for mitochondrial quality control: Mitochondrial-derived vesicles. EMBO J. (2014) 33:2142–56. doi: 10.15252/embj.201488104</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201488104</ArticleId><ArticleId IdType="pmc">PMC4282503</ArticleId><ArticleId IdType="pubmed">25107473</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson SM, Tsueng G, Sin J, Mangale V, Rahawi S, McIntyre LL, et al. . Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers. PloS Pathog. (2014) 10:e1004045. doi: 10.1371/journal.ppat.1004045</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004045</ArticleId><ArticleId IdType="pmc">PMC3983045</ArticleId><ArticleId IdType="pubmed">24722773</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin J, McIntyre L, Stotland A, Feuer R, Gottlieb RA. Coxsackievirus B escapes the infected cell in ejected mitophagosomes. J Virol. (2017) 91:e01347-17. doi: 10.1128/JVI.01347-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01347-17</ArticleId><ArticleId IdType="pmc">PMC5709598</ArticleId><ArticleId IdType="pubmed">28978702</ArticleId></ArticleIdList></Reference><Reference><Citation>Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol. (2011) 12:9–14. doi: 10.1038/nrm3028</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3028</ArticleId><ArticleId IdType="pmc">PMC4780047</ArticleId><ArticleId IdType="pubmed">21179058</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang SC, Crescitelli R, Cvjetkovic A, Belgrano V, Olofsson Bagge R, Sundfeldt K, et al. . Mitochondrial protein enriched extracellular vesicles discovered in human melanoma tissues can be detected in patient plasma. J Extracell Vesicles. (2019) 8:1635420. doi: 10.1080/20013078.2019.1635420</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2019.1635420</ArticleId><ArticleId IdType="pmc">PMC6719261</ArticleId><ArticleId IdType="pubmed">31497264</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Acunzo P, Perez-Gonzalez R, Kim Y, Hargash T, Miller C, Alldred MJ, et al. . Mitovesicles are a novel population of extracellular vesicles of mitochondrial origin altered in Down syndrome. Sci Adv. (2021) 7:eabe5085. doi: 10.1126/sciadv.abe5085</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abe5085</ArticleId><ArticleId IdType="pmc">PMC7880603</ArticleId><ArticleId IdType="pubmed">33579698</ArticleId></ArticleIdList></Reference><Reference><Citation>Soubannier V, McLelland GL, Zunino R, Braschi E, Rippstein P, Fon EA, et al. . A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr Biol. (2012) 22:135–41. doi: 10.1016/j.cub.2011.11.057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2011.11.057</ArticleId><ArticleId IdType="pubmed">22226745</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyamzaev KG, Nepryakhina OK, Saprunova VB, Bakeeva LE, Pletjushkina OY, Chernyak BV, et al. . Novel mechanism of elimination of malfunctioning mitochondria (mitoptosis): Formation of mitoptotic bodies and extrusion of mitochondrial material from the cell. Biochim Biophys Acta. (2008) 1777:817–25. doi: 10.1016/j.bbabio.2008.03.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2008.03.027</ArticleId><ArticleId IdType="pubmed">18433711</ArticleId></ArticleIdList></Reference><Reference><Citation>Soubannier V, Rippstein P, Kaufman BA, Shoubridge EA, McBride HM. Reconstitution of mitochondria derived vesicle formation demonstrates selective enrichment of oxidized cargo. PloS One. (2012) 7:e52830. doi: 10.1371/journal.pone.0052830</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052830</ArticleId><ArticleId IdType="pmc">PMC3530470</ArticleId><ArticleId IdType="pubmed">23300790</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyamzaev KG, Knorre DA, Chernyak BV. Mitoptosis, twenty years after. Biochem (Mosc). (2020) 85:1484–98. doi: 10.1134/S0006297920120020</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297920120020</ArticleId><ArticleId IdType="pubmed">33705288</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai X, Qin Y, Chen Y, Lin L, Wang T, Zhong X, et al. . Coxsackievirus B3 induces the formation of autophagosomes in cardiac fibroblasts both in vitro and in vivo . Exp Cell Res. (2016) 349:255–63. doi: 10.1016/j.yexcr.2016.10.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2016.10.020</ArticleId><ArticleId IdType="pubmed">27793649</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin ER, Hassan SA, Jenson AB, Melnick JL. Coxsackie virus B3 myocarditis in mice. An electron microscopic, immunofluorescent and virus-assay study. Am J Pathol. (1964) 44:775–97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1907062</ArticleId><ArticleId IdType="pubmed">14155025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukimura A, Deguchi H, Kitaura Y, Fujioka S, Hirasawa M, Kawamura K, et al. . Intracellular viral localization in murine coxsackievirus-B3 myocarditis. Ultrastructural study by electron microscopic in situ hybridization. Am J Pathol. (1997) 150:2061–74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1858302</ArticleId><ArticleId IdType="pubmed">9176398</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawaged S, Mota T, Piplani H, Thakur R, Lall D, McCabe E, et al. . TBK1 and GABARAP family members suppress coxsackievirus B infection by limiting viral production and promoting autophagic degradation of viral extracellular vesicles. PLoS Pathog. (2022) 18:e1010350. doi: 10.1371/journal.ppat.1010350</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010350</ArticleId><ArticleId IdType="pmc">PMC9469980</ArticleId><ArticleId IdType="pubmed">36044516</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian L, Yang Y, Li C, Chen J, Li Z, Li X, et al. . The cytotoxicity of coxsackievirus B3 is associated with a blockage of autophagic flux mediated by reduced syntaxin 17 expression. Cell Death Dis. (2018) 9:242. doi: 10.1038/s41419-018-0271-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0271-0</ArticleId><ArticleId IdType="pmc">PMC5833838</ArticleId><ArticleId IdType="pubmed">29445155</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor MP, Kirkegaard K. Modification of cellular autophagy protein LC3 by poliovirus. J Virol. (2007) 81:12543–53. doi: 10.1128/JVI.00755-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00755-07</ArticleId><ArticleId IdType="pmc">PMC2169029</ArticleId><ArticleId IdType="pubmed">17804493</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyei GB, Dinkins C, Davis AS, Roberts E, Singh SB, Dong C, et al. . Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J Cell Biol. (2009) 186:255–68. doi: 10.1083/jcb.200903070</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200903070</ArticleId><ArticleId IdType="pmc">PMC2717652</ArticleId><ArticleId IdType="pubmed">19635843</ArticleId></ArticleIdList></Reference><Reference><Citation>Gannage M, Dormann D, Albrecht R, Dengjel J, Torossi T, Ramer PC, et al. . Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe. (2009) 6:367–80. doi: 10.1016/j.chom.2009.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2009.09.005</ArticleId><ArticleId IdType="pmc">PMC2774833</ArticleId><ArticleId IdType="pubmed">19837376</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SJ, Syed GH, Khan M, Chiu WW, Sohail MA, Gish RG, et al. . Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence. Proc Natl Acad Sci U S A. (2014) 111:6413–8. doi: 10.1073/pnas.1321114111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1321114111</ArticleId><ArticleId IdType="pmc">PMC4035934</ArticleId><ArticleId IdType="pubmed">24733894</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh SJ, Lim BK, Yun J, Shin OS. CVB3-mediated mitophagy plays an important role in viral replication via abrogation of interferon pathways. Front Cell Infect Microbiol. (2021) 11:704494. doi: 10.3389/fcimb.2021.704494</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.704494</ArticleId><ArticleId IdType="pmc">PMC8292102</ArticleId><ArticleId IdType="pubmed">34295842</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasius AL, Beutler B. Intracellular Toll-like receptors. Immunity. (2010) 32:305–15. doi: 10.1016/j.immuni.2010.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.03.012</ArticleId><ArticleId IdType="pubmed">20346772</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin L, Xiao Z, Ma X, He F, Yao H, Liu Z. Coxsackievirus B3 induces crosstalk between autophagy and apoptosis to benefit its release after replicating in autophagosomes through a mechanism involving caspase cleavage of autophagy-related proteins. Infect Genet Evol. (2014) 26:95–102. doi: 10.1016/j.meegid.2014.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2014.05.005</ArticleId><ArticleId IdType="pubmed">24836289</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschope C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. . Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions. Nat Rev Cardiol. (2021) 18:169–93. doi: 10.1038/s41569-020-00435-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00435-x</ArticleId><ArticleId IdType="pmc">PMC7548534</ArticleId><ArticleId IdType="pubmed">33046850</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Beetler DJ, Di Florio DN, Musigk N, Heidecker B, Cooper LT, Jr. COVID-19, myocarditis and pericarditis. Circ Res. (2023) 132:1302–19. doi: 10.1161/CIRCRESAHA.123.321878</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.123.321878</ArticleId><ArticleId IdType="pmc">PMC10171304</ArticleId><ArticleId IdType="pubmed">37167363</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YH, Du W, Hagemeijer MC, Takvorian PM, Pau C, Cali A, et al. . Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses. Cell. (2015) 160:619–30. doi: 10.1016/j.cell.2015.01.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.01.032</ArticleId><ArticleId IdType="pmc">PMC6704014</ArticleId><ArticleId IdType="pubmed">25679758</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Zhang M, Yan R, Shan H, Diao J, Wei J. Inhibition of Drp1 attenuates mitochondrial damage and myocardial injury in coxsackievirus B3 induced myocarditis. Biochem Biophys Res Commun. (2017) 484:550–6. doi: 10.1016/j.bbrc.2017.01.116</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.01.116</ArticleId><ArticleId IdType="pubmed">28131843</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolte HD, Schultheiss HP. Immunological results in myocardial diseases. Postgraduate Med J. (1978) 54:500–4. doi: 10.1136/pgmj.54.633.500</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.54.633.500</ArticleId><ArticleId IdType="pmc">PMC2425105</ArticleId><ArticleId IdType="pubmed">704517</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss HP, Bolte HD. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol. (1985) 17:603–17. doi: 10.1016/s0022-2828(85)80029-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-2828(85)80029-8</ArticleId><ArticleId IdType="pubmed">2991541</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss HP, Schwimmbeck P, Bolte HD, Klingenberg M. The antigenic characteristics and the significance of the adenine nucleotide translocator as a major autoantigen to antimitochondrial antibodies in dilated cardiomyopathy. Adv Myocardiol. (1985) 6:311–27.</Citation><ArticleIdList><ArticleId IdType="pubmed">2581297</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE, et al. . Dilated cardiomyopathy. Nat Rev Dis Primers. (2019) 5:32. doi: 10.1038/s41572-019-0084-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-019-0084-1</ArticleId><ArticleId IdType="pmc">PMC7096917</ArticleId><ArticleId IdType="pubmed">31073128</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss HP, Klingenberg M. Immunochemical characterization of the adenine nucleotide translocator. Organ specificity and conformation specificity. Eur J Biochem. (1984) 143:599–605. doi: 10.1111/j.1432-1033.1984.tb08412.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1984.tb08412.x</ArticleId><ArticleId IdType="pubmed">6090134</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R, Maisch B, Kochsiek K, Berg PA. Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol. (1984) 58:283–92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1577059</ArticleId><ArticleId IdType="pubmed">6238732</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansari AA, Wang YC, Danner DJ, Gravanis MB, Mayne A, Neckelmann N, et al. . Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy. Am J Pathol. (1991) 139:337–54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886070</ArticleId><ArticleId IdType="pubmed">1867322</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers JM, Cooper LT, Kem DC, Stavrakis S, Kosanke SD, Shevach EM, et al. . Cardiac myosin-Th17 responses promote heart failure in human myocarditis. JCI Insight. (2016) 1:e85851. doi: 10.1172/jci.insight.85851</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.85851</ArticleId><ArticleId IdType="pmc">PMC4924810</ArticleId><ArticleId IdType="pubmed">27366791</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Beetler DJ, Musigk N, Heidecker B, Lyle MA, Cooper LT, Jr., et al. . Sex and gender differences in myocarditis and dilated cardiomyopathy: An update. Front Cardiovasc Med. (2023) 10:1129348. doi: 10.3389/fcvm.2023.1129348</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1129348</ArticleId><ArticleId IdType="pmc">PMC10017519</ArticleId><ArticleId IdType="pubmed">36937911</ArticleId></ArticleIdList></Reference><Reference><Citation>Caforio AL, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: Pathogenetic and clinical significance. Eur J Heart Fail. (2002) 4:411–7. doi: 10.1016/s1388-9842(02)00010-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1388-9842(02)00010-7</ArticleId><ArticleId IdType="pubmed">12167378</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv H, Havari E, Pinto S, Gottumukkala RV, Cornivelli L, Raddassi K, et al. . Impaired thymic tolerance to alpha-myosin directs autoimmunity to the heart in mice and humans. J Clin Invest. (2011) 121:1561–73. doi: 10.1172/JCI44583</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI44583</ArticleId><ArticleId IdType="pmc">PMC3069776</ArticleId><ArticleId IdType="pubmed">21436590</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil-Cruz C, Perez-Shibayama C, De Martin A, Ronchi F, van der Borght K, Niederer R, et al. . Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy. Science. (2019) 366:881–6. doi: 10.1126/science.aav3487</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav3487</ArticleId><ArticleId IdType="pubmed">31727837</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann DA, Rose NR, Ansari AA, Herskowitz A. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis. J Immunol. (1994) 152:343–50. doi: 10.4049/jimmunol.152.1.343</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.152.1.343</ArticleId><ArticleId IdType="pubmed">8254202</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker YLC, Duvvuri B, Fortin PR, Lood C, Boilard E. The role of mitochondria in rheumatic diseases. Nat Rev Rheumatol. (2022) 18:621–40. doi: 10.1038/s41584-022-00834-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-022-00834-z</ArticleId><ArticleId IdType="pubmed">36175664</ArticleId></ArticleIdList></Reference><Reference><Citation>Burbano C, Villar-Vesga J, Orejuela J, Munoz C, Vanegas A, Vasquez G, et al. . Potential involvement of platelet-derived microparticles and microparticles forming immune complexes during monocyte activation in patients with systemic lupus erythematosus. Front Immunol. (2018) 9:322. doi: 10.3389/fimmu.2018.00322</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00322</ArticleId><ArticleId IdType="pmc">PMC5837989</ArticleId><ArticleId IdType="pubmed">29545790</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen PM, Tsokos GC. Mitochondria in the pathogenesis of systemic lupus erythematosus. Curr Rheumatol Rep. (2022) 24:88–95. doi: 10.1007/s11926-022-01063-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-022-01063-9</ArticleId><ArticleId IdType="pubmed">35290598</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Yusung S, Frisancho S, Barrett M, Gatewood S, Steele R, et al. . IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication. J Immunol. (2003) 170:4731–7. doi: 10.4049/jimmunol.170.9.4731</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.9.4731</ArticleId><ArticleId IdType="pubmed">12707353</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson U, Kurrer MO, Sonderegger I, Iezzi G, Tafuri A, Hunziker L, et al. . Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis. J Exp Med. (2003) 197:323–31. doi: 10.1084/jem.20021788</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20021788</ArticleId><ArticleId IdType="pmc">PMC2193833</ArticleId><ArticleId IdType="pubmed">12566416</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Zhang D, Hu D, Zhou X, Zhou Y. The role of mitochondria in NLRP3 inflammasome activation. Mol Immunol. (2018) 103:115–24. doi: 10.1016/j.molimm.2018.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2018.09.010</ArticleId><ArticleId IdType="pubmed">30248487</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindler SM, Frank MG, Annis JL, Maier SF, Klegeris A. Pattern recognition receptors mediate pro-inflammatory effects of extracellular mitochondrial transcription factor A (TFAM). Mol Cell Neurosci. (2018) 89:71–9. doi: 10.1016/j.mcn.2018.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2018.04.005</ArticleId><ArticleId IdType="pubmed">29678518</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel TJ, Bajwa E, Klegeris A. Cytochrome c can be released into extracellular space and modulate functions of human astrocytes in a Toll-like receptor 4-dependent manner. Biochim Biophys Acta Gen Subj. (2019) 1863:129400. doi: 10.1016/j.bbagen.2019.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2019.07.009</ArticleId><ArticleId IdType="pubmed">31344401</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajwa E, Pointer CB, Klegeris A. The role of mitochondrial damage-associated molecular patterns in chronic neuroinflammation. Mediators Inflamm. (2019) 2019:4050796. doi: 10.1155/2019/4050796</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/4050796</ArticleId><ArticleId IdType="pmc">PMC6466851</ArticleId><ArticleId IdType="pubmed">31065234</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray TE, Wenzel TJ, Simtchouk S, Greuel BK, Gibon J, Klegeris A. Extracellular cardiolipin modulates select immune functions of astrocytes in Toll-like receptor (TLR) 4-dependent manner. Mediators Inflamm. (2022) 2022:9946439. doi: 10.1155/2022/9946439</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/9946439</ArticleId><ArticleId IdType="pmc">PMC8975658</ArticleId><ArticleId IdType="pubmed">35369030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda G, Santoso MR, Tada Y, Li AM, Vaskova E, Jung JH, et al. . Mitochondria-rich extracellular vesicles from autologous stem cell-derived cardiomyocytes restore energetics of ischemic myocardium. J Am Coll Cardiol. (2021) 77:1073–88. doi: 10.1016/j.jacc.2020.12.060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.12.060</ArticleId><ArticleId IdType="pmc">PMC8626617</ArticleId><ArticleId IdType="pubmed">33632482</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien CG, Ozen MO, Ikeda G, Vaskova E, Jung JH, Bayardo N, et al. . Mitochondria-rich extracellular vesicles rescue patient-specific cardiomyocytes from doxorubicin injury: Insights into the SENECA Trial. JACC CardioOncol. (2021) 3:428–40. doi: 10.1016/j.jaccao.2021.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccao.2021.05.006</ArticleId><ArticleId IdType="pmc">PMC8463733</ArticleId><ArticleId IdType="pubmed">34604804</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Gao Y, Liu J, Huang Y, Yin J, Feng Y, et al. . Intercellular mitochondrial transfer as a means of tissue revitalization. Signal Transduct Target Ther. (2021) 6:65. doi: 10.1038/s41392-020-00440-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00440-z</ArticleId><ArticleId IdType="pmc">PMC7884415</ArticleId><ArticleId IdType="pubmed">33589598</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemente-Suarez VJ, Martin-Rodriguez A, Yanez-Sepulveda R, Tornero-Aguilera JF. Mitochondrial transfer as a novel therapeutic approach in disease diagnosis and treatment. Int J Mol Sci. (2023) 24:8848. doi: 10.3390/ijms24108848</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24108848</ArticleId><ArticleId IdType="pmc">PMC10218908</ArticleId><ArticleId IdType="pubmed">37240194</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson MS, Su MA. AIRE expands: New roles in immune tolerance and beyond. Nat Rev Immunol. (2016) 16:247–58. doi: 10.1038/nri.2016.9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.9</ArticleId><ArticleId IdType="pmc">PMC4831132</ArticleId><ArticleId IdType="pubmed">26972725</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa H, Matsumoto T. Mechanisms of tolerance induction by dendritic cells in vivo . Front Immunol. (2018) 9:350. doi: 10.3389/fimmu.2018.00350</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00350</ArticleId><ArticleId IdType="pmc">PMC5834484</ArticleId><ArticleId IdType="pubmed">29535726</ArticleId></ArticleIdList></Reference><Reference><Citation>Rath S, Sharma R, Gupta R, Ast T, Chan C, Durham TJ, et al. . MitoCarta3.0: An updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. (2021) 49:D1541–D7. doi: 10.1093/nar/gkaa1011</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1011</ArticleId><ArticleId IdType="pmc">PMC7778944</ArticleId><ArticleId IdType="pubmed">33174596</ArticleId></ArticleIdList></Reference><Reference><Citation>LaFlam TN, Seumois G, Miller CN, Lwin W, Fasano KJ, Waterfield M, et al. . Identification of a novel cis-regulatory element essential for immune tolerance. J Exp Med. (2015) 212:1993–2002. doi: 10.1084/jem.20151069</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20151069</ArticleId><ArticleId IdType="pmc">PMC4647269</ArticleId><ArticleId IdType="pubmed">26527800</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal K, Yoshida H, Benoist C, Mathis D. The transcriptional regulator AIRE binds to and activates super-enhancers. Nat Immunol. (2017) 18:263–73. doi: 10.1038/ni.3675</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3675</ArticleId><ArticleId IdType="pmc">PMC5310976</ArticleId><ArticleId IdType="pubmed">28135252</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>